McKesson, CVS Health Extend Pharmaceutical Distribution Agreement

09:02 AM EDT, 10/01/2026 (MT Newswires) -- McKesson (MCK) has signed an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health (CVS) through June 2032, the company said Wednesday. Under the extended agreement, McKesson will distribute pharmaceuticals to CVS Health's mail-order, specialty pharmacies, retail pharmacies and distribution centers. Additionally, McKesson reaffirmed its fiscal 2027 adjusted EPS guidance of $44.20 to $45 and its long-term adjusted EPS growth target of 13% to 16%. Analysts polled by FactSet expect $44.64.